M
Maria Molina
Researcher at University of Pennsylvania
Publications - 46
Citations - 397
Maria Molina is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 9, co-authored 31 publications receiving 270 citations. Previous affiliations of Maria Molina include Hospital of the University of Pennsylvania.
Papers
More filters
Journal ArticleDOI
Trends in Mechanical Support Use as a Bridge to Adult Heart Transplant Under New Allocation Rules.
Thomas C. Hanff,Michael O. Harhay,Stephen E. Kimmel,Maria Molina,Jeremy A. Mazurek,Lee R. Goldberg,Edo Y. Birati +6 more
TL;DR: This study investigates trends in mechanical support use after implementation of the Organ Procurement and Transplantation Network’s new heart transplant allocation rules.
Journal ArticleDOI
Successful cardiac transplantation outcomes in patients with adult congenital heart disease
Jonathan N. Menachem,Jessica R. Golbus,Maria Molina,Jeremy A. Mazurek,Nicole Hornsby,Pavan Atluri,Stephanie Fuller,Edo Y. Birati,Yuli Y. Kim,Lee R. Goldberg,Joyce Wald +10 more
TL;DR: Patients with congenital heart disease undergoing heart transplantation by adult cardiac surgeons in a large academic medical centre are characterised to describe successful outcomes associated with the multidisciplinary approach to the evaluation and treatment of adults with congenITAL heart disease (ACHD) undergoing orthotopic heart transplants (OHT).
Journal ArticleDOI
Correlation of circulating donor-specific anti-HLA antibodies and presence of C4d in endomyocardial biopsy with heart allograft outcomes: a single-center, retrospective study.
TL;DR: Episodes of ACR and CAV, but not AMR, appeared to be more frequently associated with graft dysfunction in patients with circulating DSA, and patients with DSA to class I, II or both were seen to be at risk for CAV.
Journal ArticleDOI
Circulating donor-specific anti-human leukocyte antigen antibodies and complement C4d deposition are associated with the development of cardiac allograft vasculopathy.
TL;DR: Compared with the general HTR population, patients with graft dysfunction and DSA or positive C4d on EMB show a statistically significant increased incidence of CAV and allograft failure, suggesting an antibody-mediated injury.
Journal ArticleDOI
Causes, Preventability, and Cost of Unplanned Rehospitalizations Within 30 Days of Discharge After Lung Transplantation.
Andrew M. Courtwright,D. Zaleski,Lisa Gardo,Vivek N. Ahya,Jason D. Christie,Maria M. Crespo,Denis Hadjiliadis,James C. Lee,Maria Molina,Namrata Patel,Mary K. Porteous,Edward E. Cantu,Christian A. Bermudez,Joshua M. Diamond +13 more
TL;DR: Although clinicians do not rate the majority of UR after lung transplant as preventable, discharge frailty is associated with UR, and further research should identify whether modification of discharged frailty can reduce UR.